Conference Coverage (ICAAC)

Rifampin Resistance Rises Among HIV Infected in NYC

Published in TB and Outbreaks Week, October 7th, 1996

A rise in rifampin resistance only (mono-resistance) among the HIV infected in New York City is only partly due to therapeutic non-adherence, and malabsorption has not been ruled out.

A U.S. Centers for Disease Control and Prevention (CDC) study found that 1.5 percent of TB cases reported in New York City between 1993 and 1994 were mono-rifampin resistant.

The study was outlined in a poster presentation at the 36th Meeting of the American Society for Microbiology's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 15-18, 1996 in New Orleans, Louisiana.

There were 99 cases of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1996-10-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry